KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $33.8 million.

  • Dynavax Technologies' Cash from Operations rose 7377.61% to $33.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.6 million, marking a year-over-year increase of 23238.71%. This contributed to the annual value of $66.5 million for FY2024, which is 3386.04% down from last year.
  • Dynavax Technologies' Cash from Operations amounted to $33.8 million in Q3 2025, which was up 7377.61% from $23.4 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Cash from Operations registered a high of $120.5 million during Q4 2021, and its lowest value of -$50.4 million during Q1 2022.
  • For the 5-year period, Dynavax Technologies' Cash from Operations averaged around $31.7 million, with its median value being $28.0 million (2023).
  • Per our database at Business Quant, Dynavax Technologies' Cash from Operations surged by 86540.05% in 2021 and then crashed by 23263.3% in 2022.
  • Dynavax Technologies' Cash from Operations (Quarter) stood at $120.5 million in 2021, then crashed by 71.0% to $34.9 million in 2022, then plummeted by 60.61% to $13.8 million in 2023, then skyrocketed by 285.09% to $53.0 million in 2024, then crashed by 36.18% to $33.8 million in 2025.
  • Its Cash from Operations was $33.8 million in Q3 2025, compared to $23.4 million in Q2 2025 and -$19.6 million in Q1 2025.